Array BioPharma (ARRY) stock was tumbling in late-afternoon trading after the company's cancer drug trial failed to meet its primary endpoint.
Trade-Ideas LLC identified Array BioPharma (ARRY) as a pre-market mover with heavy volume candidate
Biotech stocks remain pressured following the recent Brexit vote, which will make investing in these already highly volatile stocks even trickier. But there are opportunities too.
Trade-Ideas LLC identified Array BioPharma (ARRY) as a weak on high relative volume candidate